SI9111779B - Lhrh-antagonists. - Google Patents

Lhrh-antagonists. Download PDF

Info

Publication number
SI9111779B
SI9111779B SI9111779A SI9111779A SI9111779B SI 9111779 B SI9111779 B SI 9111779B SI 9111779 A SI9111779 A SI 9111779A SI 9111779 A SI9111779 A SI 9111779A SI 9111779 B SI9111779 B SI 9111779B
Authority
SI
Slovenia
Prior art keywords
leu7
pro1
nac
ser4
arg8
Prior art date
Application number
SI9111779A
Other languages
English (en)
Other versions
SI9111779A (en
Inventor
Shaobo Xiao
Original Assignee
Tianjin Municipal Res Inst For
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Municipal Res Inst For filed Critical Tianjin Municipal Res Inst For
Publication of SI9111779A publication Critical patent/SI9111779A/sl
Publication of SI9111779B publication Critical patent/SI9111779B/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Claims (8)

  1. PATENTNI ZAHTEVKI 1. Postopek za konstruiranje in sintezo antagonistov LHRH-ja, označen s tem, da se kot izhodna spojina vzame zelo učinkovit antagonist LHRH-ja (NAc-D2Nal1, DpCIPhe2, D3Pal3, Ser4, Tyr\ DArg6, Leu7, Arg8, Pro1, DAIa2)NH2 (II) in se z modifikacijo tako alkalnega kot lipofilnega področja molekule (II) dobijo novi antagonisti LHRH-ja.
  2. 2. Spojina v skladu z zahtevkom 1, označena s tem, da je izražena s formulo (NAc-D2Nal\ DpCIPhe2, DPhe3, Ser4, Arg5, D3Pal6, Leu7, Arg8, Pro1, DAIa2)NH2.
  3. 3. Spojina v skladu z zahtevkom 1, označena s tem, da je izražena s formulo (Nac-D2Nal1, DpCIPhe2, DPhe3, Ser4, Τγι·5, D3Pal6, Leu7, Arg8, Pro1, DAla2) NH2.
  4. 4. (N-AC-D2Nal1, P-CI-D-Phe2, D3Pal3, Ser4, Mop5, D3Pal6, Leu7, Arg8, Pro1, D-Ala2)NH2.
  5. 5. (N-AC-D-2Nal1, D-Phe2, D3Pal3, Ser4, Mop5, D3Pal6, Leu7, Arg8, Pro1, D-Ala2)NH2.
  6. 6. (N-AC-D-2Nal\ P-CI-D-Phe2, D3Pal3, Set4, Arg5, D3Pal8, Leu7, Pap8, Pro1, D-Ala2)NH2.
  7. 7. Postopek konstruiranja in sinteze v skladu z zahtevkom 1, označen s tem, da se dobi spojina v skladu z zahtevkom 4.
  8. 8. Postopek konstruiranja in sinteze v skladu z zahtevkom 1, označen s tem, da se dobi spojina v skladu z zahtevkom 5. 1 Postopek konstruiranja in sinteze v skladu z zahtevkom 1, označen s tem, da se dobi 2 spojina v skladu z zahtevkom 6.
SI9111779A 1990-11-10 1991-11-08 Lhrh-antagonists. SI9111779B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN90108955A CN1036343C (zh) 1990-11-10 1990-11-10 新促黄体生成素释放激素拮抗类似物的制备方法
YU177991A YU48831B (sh) 1990-11-10 1991-11-08 Lhrh - antagonisti i postupak za njihovu proizvodnju

Publications (2)

Publication Number Publication Date
SI9111779A SI9111779A (en) 1997-04-30
SI9111779B true SI9111779B (en) 2001-12-31

Family

ID=4881223

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9111779A SI9111779B (en) 1990-11-10 1991-11-08 Lhrh-antagonists.

Country Status (29)

Country Link
EP (1) EP0564466B1 (sl)
KR (1) KR100244624B1 (sl)
CN (1) CN1036343C (sl)
AT (1) ATE149520T1 (sl)
AU (1) AU662496B2 (sl)
CA (1) CA2095932C (sl)
CZ (1) CZ284168B6 (sl)
DE (1) DE69125024T2 (sl)
DK (1) DK0564466T3 (sl)
EE (1) EE03141B1 (sl)
ES (1) ES2100965T3 (sl)
FI (1) FI933156A0 (sl)
GR (1) GR3023389T3 (sl)
HR (1) HRP920585B1 (sl)
IE (1) IE913915A1 (sl)
LT (1) LT3971B (sl)
LV (1) LV10106B (sl)
NO (1) NO931697L (sl)
NZ (1) NZ240505A (sl)
PH (1) PH31178A (sl)
PL (1) PL170564B1 (sl)
PT (1) PT99458B (sl)
RU (1) RU2123499C1 (sl)
SI (1) SI9111779B (sl)
SK (1) SK281319B6 (sl)
UA (1) UA41300C2 (sl)
WO (1) WO1992008733A1 (sl)
YU (1) YU48831B (sl)
ZA (1) ZA918847B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2136079A1 (en) * 1992-12-18 1994-07-07 Fortuna Haviv Lhrh antagonists having modified aminoacyl residues at positions 5 and 6
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
DE4338015A1 (de) * 1993-11-08 1995-05-11 Asta Medica Ag Verwendung von D-glucopyranuronsäuren und deren Derivaten zum Einbau in pharmakologisch wirksame Peptide und deren Salze
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
CN103524599B (zh) * 2012-07-05 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 环肽lhrh拮抗剂衍生物及其药物用途
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity

Also Published As

Publication number Publication date
CZ84893A3 (en) 1994-02-16
CN1061605A (zh) 1992-06-03
FI933156A (fi) 1993-07-09
PH31178A (en) 1998-03-20
FI933156A0 (fi) 1993-07-09
EE03141B1 (et) 1998-12-15
NO931697L (no) 1993-07-07
CA2095932A1 (en) 1992-05-11
ATE149520T1 (de) 1997-03-15
CZ284168B6 (cs) 1998-09-16
KR100244624B1 (ko) 2000-02-15
LT3971B (en) 1996-05-27
UA41300C2 (uk) 2001-09-17
PL170564B1 (pl) 1996-12-31
LV10106B (en) 1995-04-20
PL295427A1 (en) 1993-09-06
DE69125024T2 (de) 1997-07-17
ZA918847B (en) 1992-08-26
LV10106A (lv) 1994-05-10
LTIP1513A (en) 1995-06-26
WO1992008733A1 (en) 1992-05-29
GR3023389T3 (en) 1997-08-29
NZ240505A (en) 1993-04-28
NO931697D0 (no) 1993-05-10
SI9111779A (en) 1997-04-30
HRP920585A2 (en) 1997-04-30
RU2123499C1 (ru) 1998-12-20
DE69125024D1 (de) 1997-04-10
DK0564466T3 (da) 1997-08-25
ES2100965T3 (es) 1997-07-01
CN1036343C (zh) 1997-11-05
PT99458B (pt) 1999-02-26
PT99458A (pt) 1992-10-30
EP0564466B1 (en) 1997-03-05
YU177991A (sh) 1994-06-24
IE913915A1 (en) 1992-05-20
CA2095932C (en) 2003-02-25
EP0564466A1 (en) 1993-10-13
SK45393A3 (en) 1993-10-06
YU48831B (sh) 2002-03-18
AU662496B2 (en) 1995-09-07
SK281319B6 (sk) 2001-02-12
AU8861291A (en) 1992-06-11
HRP920585B1 (en) 2000-08-31
KR930703353A (ko) 1993-11-29

Similar Documents

Publication Publication Date Title
DE3850789T2 (de) Nonapeptid- und Dekapeptid-Analoge von LHRH, die als LHRH-Antagonisten dienen.
SU1428205A3 (ru) Способ получени декапептидов или их фармацевтически приемлемых солей
US5169932A (en) Gnrh analogs
US5565574A (en) Preparation of phenylalanine derivatives bearing a 1,2,4-triazole moiety and their use in peptides
DE3587016T2 (de) Nona- und dekapeptidanaloga von lhrh, welche als lhrh-antagonisten dienen.
SI9111779B (en) Lhrh-antagonists.
DE4119856A1 (de) N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
JPS59181258A (ja) 医薬用組成物
EP0575490B1 (en) GnRH ANALOGS
ES2044901T3 (es) Procedimiento para la preparacion de un derivado de imidazol y su utilizacion.
DE2547721A1 (de) Biologisch aktive amide
RU93004994A (ru) Продукты, применение и способ получения антагонистов гормона, стимулирующего выделение лютеинизирующего гормона

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20090616